These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22192144)

  • 1. Airway inflammation evaluated in a human nasal lipopolysaccharide challenge model by investigating the effect of a CXCR2 inhibitor.
    Virtala R; Ekman AK; Jansson L; Westin U; Cardell LO
    Clin Exp Allergy; 2012 Apr; 42(4):590-6. PubMed ID: 22192144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of LPS-induced airway neutrophilic inflammation in healthy volunteers with an oral CXCR2 antagonist.
    Leaker BR; Barnes PJ; O'Connor B
    Respir Res; 2013 Dec; 14(1):137. PubMed ID: 24341382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal challenge with allergen leads to maxillary sinus inflammation.
    Baroody FM; Mucha SM; Detineo M; Naclerio RM
    J Allergy Clin Immunol; 2008 May; 121(5):1126-1132.e7. PubMed ID: 18367240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal challenge with LPS stimulates the release of macrophage inflammatory protein 1alpha.
    Ekman AK; Fransson M; Rydberg C; Adner M; Cardell LO
    Int Arch Allergy Immunol; 2009; 149(2):154-60. PubMed ID: 19127073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myeloperoxidase (MPO) as a marker of neutrophil influx into nasal mucosa after recombinant IL-8 challenge].
    Kupczyk M; Bocheńska-Marciniak M; Górski P; Kuna P
    Pneumonol Alergol Pol; 2002; 70(11-12):544-9. PubMed ID: 12884563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide administration to the allergic nose contributes to lower airway inflammation.
    Bachar O; Gustafsson J; Jansson L; Adner M; Cardell LO
    Clin Exp Allergy; 2007 Dec; 37(12):1773-80. PubMed ID: 17941911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge.
    Ciprandi G; Tosca MA; Passalacqua G; Canonica GW
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):433-8. PubMed ID: 11345288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide-induced down-regulation of uteroglobin in the human nose.
    Fransson M; Adner M; Uddman R; Cardell LO
    Acta Otolaryngol; 2007 Mar; 127(3):285-91. PubMed ID: 17364366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis.
    Bonay M; Neukirch C; Grandsaigne M; Leçon-Malas V; Ravaud P; Dehoux M; Aubier M
    Allergy; 2006 Jan; 61(1):111-8. PubMed ID: 16364165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects.
    Holz O; Khalilieh S; Ludwig-Sengpiel A; Watz H; Stryszak P; Soni P; Tsai M; Sadeh J; Magnussen H
    Eur Respir J; 2010 Mar; 35(3):564-70. PubMed ID: 19643947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of TNFalpha on the human nasal mucosa in vivo.
    Widegren H; Korsgren M; Andersson M; Greiff L
    Respir Med; 2007 Sep; 101(9):1982-7. PubMed ID: 17532197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals.
    Gordon JR; Li F; Zhang X; Wang W; Zhao X; Nayyar A
    J Leukoc Biol; 2005 Dec; 78(6):1265-72. PubMed ID: 16204619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study.
    Rimmer J; Peake HL; Santos CM; Lean M; Bardin P; Robson R; Haumann B; Loehrer F; Handel ML
    Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1 receptor antagonist reduces endotoxin-induced airway inflammation in healthy volunteers.
    Hernandez ML; Mills K; Almond M; Todoric K; Aleman MM; Zhang H; Zhou H; Peden DB
    J Allergy Clin Immunol; 2015 Feb; 135(2):379-85. PubMed ID: 25195169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis.
    de Graaf-in 't Veld T; Garrelds IM; van Toorenenbergen AW; Mulder PG; Gerth van Wijk R; Boegheim JP
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):261-6. PubMed ID: 7552929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of alpha 2-macroglobulin into human nasal airways.
    Greiff L; Andersson M; Svensson C; Persson CG
    Clin Exp Allergy; 1997 Apr; 27(4):438-44. PubMed ID: 9146938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of interleukin-8 challenge in the nasal mucosa in atopic and nonatopic subjects.
    Douglass JA; Dhami D; Gurr CE; Bulpitt M; Shute JK; Howarth PH; Lindley IJ; Church MK; Holgate ST
    Am J Respir Crit Care Med; 1994 Oct; 150(4):1108-13. PubMed ID: 7921444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Objective monitoring of nasal airway inflammation in rhinitis.
    Howarth PH; Persson CG; Meltzer EO; Jacobson MR; Durham SR; Silkoff PE
    J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S414-41. PubMed ID: 15746881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intranasal challenge with interleukin-6 on upper airway symptomatology and physiology in allergic and nonallergic patients.
    Gentile DA; Yokitis J; Angelini BL; Doyle WJ; Skoner DP
    Ann Allergy Asthma Immunol; 2001 May; 86(5):531-6. PubMed ID: 11379804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.